Quadruple Antigen Virus Like Particle (VLP) Vaccine candidate for SARS COV2 and method thereof
The present Invention relates to the development of Quadruple Antigen Virus Like Particle (VLP) Vaccine candidate for SARS COV2 in Pichia pastoris expression host.